Viewing nowGlipham Tablet 4 mg (Glimepiride)
Glimepiride 4mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

MFDS item code 200709818 · Notified 2007.08.27 · Insurance code 642900030
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone and, if blood sugar control is insufficient, it may be used in combination with other antihyperglycemic agents such as insulin or metformin. It helps improve blood sugar control through various treatment methods.
The dose should be adjusted individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medication is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medication. Monotherapy: In patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit at doses above 4 mg, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using insulin or another oral antidiabetic medication in combination. As treatment progresses, improved control of diabetes may reduce the amount of this medication needed. Therefore, a dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. When switching from another oral glucose-lowering medication to this medication, it is recommended to follow the instructions given under Initial Dosage. That is, start with 1 mg daily, and the dose may be adjusted at intervals of 1 ~ 2 weeks. The potency and duration of action of the medication previously used should be taken into account. While taking this medication, blood glucose and/or urine glucose levels should be measured regularly. Regular measurement of hemoglobin A1c (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. Combination therapy with insulin: Combination therapy with this medication and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medication once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and hemoglobin A1c. Combination therapy with metformin: If the patient does not respond adequately to the maximum dose of this medication, the addition of metformin may be considered. When this medication is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medication. However, efforts should be made to identify the minimum effective dose of each medication needed to control blood glucose. There is a risk of hypoglycemia when this medication is used with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be administered to patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a state of coma. Patients allergic to this medication, its components, sulfonylureas, or sulfonamides should also refrain from use. For patients with severely impaired liver or kidney function, it is recommended to switch to insulin therapy instead of using this medication. Pregnant or potentially pregnant women and nursing mothers should not take this medication. Patients with severe infections, before and after surgery, or those who have suffered serious trauma may also require insulin therapy and should use this medication cautiously. In cases of diarrhea or vomiting that affect food absorption, there is a risk of hypoglycemia, so caution is needed. During the first week of treatment, there is a heightened risk of hypoglycemia, so blood sugar should be checked frequently. Older adults, patients with poor nutritional status or those who eat irregularly, individuals whose exercise levels do not match carbohydrate intake, and those who frequently consume alcohol are also at higher risk for hypoglycemia, so they should be careful. Patients with weak liver or kidney function, as well as those with other endocrine disorders, may also respond sensitively to this medication, so consultation with a specialist is advised. This medication can cause hypoglycemia, with symptoms including headache, severe hunger, vomiting, fatigue, anxiety, confusion, drowsiness, and in severe cases, loss of consciousness. If hypoglycemic symptoms appear, sugar should be consumed immediately, and if symptoms persist or worsen, medical staff should be informed. Additionally, blurred vision, gastrointestinal symptoms, liver dysfunction, blood dyscrasia, and allergic reactions may occur, so if any abnormal symptoms arise, consult a physician immediately. During the course of taking this medication, regular meals, exercise, and weight management are crucial, and it is important to always carry sugar to prepare for hypoglycemia and to be well-informed about hypoglycemic symptoms and treatment methods. When combined with other medications, blood sugar control may be affected, so it is essential to disclose any concurrent medications. Pregnant or nursing women should not take this medication, and if necessary, they should switch to insulin therapy. In cases of overdose, the risk of severe hypoglycemia may increase, so immediate medical attention is required, and careful monitoring should continue for at least 24-48 hours after treatment.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to avoid exposure to air or moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius.
Pale blue rectangular tablet
30 tablets, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 4mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.